Polar Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,670,649
Closed -$54.5M 288
2020
Q1
$54.5M Buy
1,670,649
+315,454
+23% +$12.3M 0.59% 48
2019
Q4
$61.3M Sell
1,355,195
-219,029
-14% -$9.16M 0.53% 50
2019
Q3
$64.1M Buy
1,574,224
+554,246
+54% +$23.5M 0.58% 46
2019
Q2
$43.8M Sell
1,019,978
-480,022
-32% -$18.5M 0.38% 85
2019
Q1
$57.6M Buy
1,500,000
+250,000
+20% +$9.55M 0.53% 60
2018
Q4
$44.2M Buy
+1,250,000
New +$45.3M 0.47% 67
2018
Q1
Sell
-327,000
Closed -$8.11M 261
2017
Q4
$8.11M Buy
327,000
+22,734
+7% +$627K 0.08% 178
2017
Q3
$8.87M Hold
304,266
0.1% 174
2017
Q2
$8.43M Sell
304,266
-1,260,734
-81% -$33.5M 0.11% 157
2017
Q1
$38.9M Hold
1,565,000
0.58% 52
2016
Q4
$33.9M Buy
1,565,000
+725,000
+86% +$15.8M 0.54% 50
2016
Q3
$20M Buy
840,000
+190,000
+29% +$4.53M 0.35% 94
2016
Q2
$15.2M Sell
650,000
-413,081
-39% -$8.94M 0.29% 105
2016
Q1
$20M Sell
1,063,081
-819,469
-44% -$14.4M 0.38% 82
2015
Q4
$34.7M Buy
+1,882,550
New +$33.7M 0.63% 51

Other funds holding BSX

Polar Capital's BSX Position: Q2 2020 in Review

Polar Capital sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 1,670,649 shares — an estimated $54.5M sold.

Polar Capital first reported a position in BSX in Q4 2015 and held it in 15 quarters. The position peaked at $64.1M in Q3 2019. 840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • Polar Capital reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
  • Polar Capital sold 1,670,649 Boston Scientific shares in Q2 2020, an estimated $54.5M.
  • Polar Capital first reported a position in Boston Scientific in Q4 2015 and held it in 15 quarters.
  • Polar Capital's Boston Scientific position peaked at $64.1M in Q3 2019.
  • 840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.